Can Huang
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
-
- Cancer, Lipids, and Metabolism 4
-
- RNA modifications and cancer 4
- Cell death mechanisms and regulation 3
-
- Ferroptosis and cancer prognosis 5
-
- Glioma Diagnosis and Treatment 2
-
- Endoplasmic Reticulum Stress and Disease 2
-
- Neuroblastoma Research and Treatments 2
- Co-authors
- Patricia Santofimia‐CastañoJuan IovannaLing PengWenjun LanYi XiaMing ShenJosé L. NeiraYourong Duan
- Journals
- Journal of Clinical Investigation (1 paper)ACS Applied Materials & Interfaces (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Can Huang
19 papers receiving 556 citations
Peers
Comparison fields: 5 of 85
- Biomaterials 117
- Cancer Research 109
- Molecular Biology 323
- Molecular Medicine 22
- Oncology 101
Countries citing papers authored by Can Huang
This map shows the geographic impact of Can Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Huang more than expected).
Fields of papers citing papers by Can Huang
This network shows the impact of papers produced by Can Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Huang. The network helps show where Can Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Can Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 13 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 47 | |
| 8 | 2021 | 38 | |
| 9 | 2021 | 44 | |
| 10 | 2020 | 33 | |
| 11 | 2020 | 27 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 4 | |
| 14 | 2020 | 1 | |
| 15 | 2019 | 79 | |
| 16 | 2019 | 34 | |
| 17 | 2017 | 71 | |
| 18 | 2015 | 14 | |
| 19 | 2015 | 90 | |
| 20 | 2015 | 1 |
About Can Huang
Can Huang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 23 papers that have together received 559 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (4 papers), RNA modifications and cancer (4 papers), Cell death mechanisms and regulation (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Glioma Diagnosis and Treatment (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Biomaterials (117 citations), Cancer Research (109 citations) and Molecular Biology (323 citations). Can Huang has collaborated with scholars based in China, France and United States. Frequent co-authors include Patricia Santofimia‐Castaño, Juan Iovanna, Ling Peng, Wenjun Lan, Yi Xia, Ming Shen, José L. Neira, Yourong Duan, Xiangyu Zhang and Ying Sun. Their work appears in journals such as Journal of Clinical Investigation, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.